Relypsa Announces Key Data Presented at ASN on Long-Term Chronic Treatment and Early Onset of Action With Patiromer for Oral Suspension Pre-Specified Sub-Analysis of Patients With Type II Diabetes From Phase 3 Trial Also Presented REDWOOD CITY, Calif., Nov. 17, 2014...
IlluminOss Medical Announces Conditional FDA Approval for Clinical Trials of Groundbreaking Photodynamic Bone Stabilization System in the U.S. Currently Recruiting Clinical Sites for Trial that May Offer Significant Advantages to Surgeons Treating Impending and...
James R. Tobin, Former CEO of Boston Scientific, Joins Oxford Immunotec Board of Directors OXFORD, United Kingdom and MARLBOROUGH, Mass., Dec. 2, 2014 (GLOBE NEWSWIRE) — Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage diagnostics company...
MEI Pharma Completes Enrollment in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia Interim Data from 33 Evaluable Patients to be Presented at ASH on Saturday SAN DIEGO, Dec. 2, 2014 /PRNewswire/ — MEI Pharma, Inc. (Nasdaq: MEIP), an oncology...
MEI Pharma Reports Significant Clinical Activity in Phase II Study of Pracinostat in Front Line Acute Myeloid Leukemia Company Outlines Plans for Phase III Registration Study San Diego, Dec. 8, 2014 /PRNewswire/ — MEI Pharma, Inc. (Nasdaq: MEIP), an oncology...
CareFusion and Kit Check to Help Providers Save Time and Improve Medication Safety from the Pharmacy to the OR ANAHEIM, Calif., December 8, 2014 – Kit Check™ (kitcheck.com), the leader in hospital pharmacy kit processing and medication tracking software, and...
Recent Comments